放射治疗加重大肠癌的促瘤性神经支配与神经信号传导
研究分析直肠癌患者神经周围侵犯(PNI)与生存的关系,并用原位小鼠直肠癌模型观察短程放疗(SCRT)对神经支配和神经信号的影响。结果显示PNI患者总生存下降,SCRT上调神经发生相关基因、增加局部去甲肾上腺素(NE)分泌和β2肾上腺素能受体(B2AR)表达;异丙肾上腺素降低SCRT疗效,普萘洛尔可阻断该效应。
要点
- 直肠癌伴神经周围侵犯(PNI)患者的总生存较无PNI患者下降。
- 小鼠模型中SCRT增加局部去甲肾上腺素分泌并上调β2肾上腺素能受体表达。
- 异丙肾上腺素降低SCRT疗效,普萘洛尔可阻断该效应。
核心结论
- 研究结果表明,短程放疗(SCRT)虽是有价值的治疗,但伴随对神经系统的不良影响,可能削弱疗效并促进肿瘤负荷。
- 作者推测,未来联合靶向该信号级联或抑制神经生长的治疗可能与SCRT联合获益。
研究设计与样本
- 获取Wilmot癌症研究所治疗的直肠癌患者病历并分析PNI状态。
- 采用既往建立的原位小鼠直肠癌模型:将表达荧光素酶的小鼠结肠-38(MC38-luc)肿瘤细胞注射至C57BL6小鼠直肠壁。
- 对肿瘤给予靶向SCRT方案:每次5 Gy,连续5次。
主要发现
- 人直肠癌伴PNI患者较无PNI患者总生存下降。
- 小鼠模型中SCRT诱导神经发生相关基因表达、增加局部去甲肾上腺素分泌并上调β2肾上腺素能受体表达。
- 异丙肾上腺素处理小鼠导致总生存下降、转移率增加并降低SCRT疗效。
- 使用普萘洛尔阻断β肾上腺素能受体可消除异丙肾上腺素引起的SCRT疗效下降。
临床怎么用
- 原文未据此给出临床推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Many solid tumors present with perineural invasion (PNI), and innervation correlates with worsened prognosis. The effects that commonly administered therapies such as radiation therapy (RT) have on PNI status remain unknown. We investigated the contribution of RT on the nervous system and elucidated the implications that increased nerve signaling can have on tumor burden using our previously developed orthotopic murine model of rectal cancer (RC) and our targeted and clinically relevant short-course RT (SCRT) regimen. METHODS: Medical charts for patients with RC treated at the Wilmot Cancer Institute were obtained and PNI status was analyzed. Human data were accompanied by an orthotopic murine model of RC. Briefly, luciferase-expressing murine colon-38 (MC38-luc) tumor cells were injected orthotopically into the rectal wall of C57BL6 mice. Targeted SCRT (5 gray (Gy) per fraction for 5 consecutive fractions) was administered to the tumor. Intratumoral innervation was determined by immunohistochemistry (IHC), local norepinephrine (NE) concentration was quantified by enzyme-linked immunosorbent assay (ELISA), and β2-adrenergic receptor (B2AR) expression was assessed by flow cytometry. Chronic NE signaling was mirrored by daily isoproterenol treatment, and the effect on tumor burden was determined by overall survival, presence of metastatic lesions, and tumor size. Isoproterenol signaling was inhibited by administration of propranolol. RESULTS: Human RC patients with PNI have decreased overall survival compared with patients without PNI. In our mouse model, SCRT induced the expression of genes involved in neurogenesis, increased local NE secretion, and upregulated B2AR expression. Treating mice with isoproterenol resulted in decreased overall survival, increased rate of metastasis, and reduced SCRT efficacy. Interestingly, the isoproterenol-induced decrease in SCRT efficacy could be abrogated by blocking the BAR through the use of propranolol, suggesting a direct role of BAR stimulation on impairing SCRT responses. CONCLUSIONS: Our results indicate that while SCRT is a valuable treatment, it is accompanied by adverse effects on the nervous system that may impede the efficacy of therapy and promote tumor burden. Therefore, we could speculate that therapies aimed at targeting this signaling cascade or impairing nerve growth in combination with SCRT may prove beneficial in future cancer treatment.
引用
- Uccello TP, Lesch ML, Ullman NA, et al. Radiation Therapy Exacerbates Tumor-Promoting Innervation and Nerve Signaling in Rectal Cancer. Int J Radiat Oncol Biol Phys. 2022. PMID: 36202180. doi:10.1016/j.ijrobp.2022.09.080
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。